Join
Live feed
·
PRReleasevia Quantisnow
ProQR Therapeutics N.V. logo

ProQR Announces Additional Sepofarsen Illuminate Trial Analyses and Provides Update on Company Strategy

ByQuantisnow·Wall Street's wire, on your screen.
PRQR· ProQR Therapeutics N.V.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRQR (ProQR Therapeutics N.V.) and more on Quantisnow.